| Product Code: ETC4720327 | Publication Date: Nov 2023 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Cyprus experienced a significant increase in human insulin import shipments in 2024, with top exporting countries being Metropolitan France, Belgium, Denmark, UK, and USA. The market concentration, as indicated by the HHI, reached very high levels in 2024 compared to the already high concentration in 2023. The impressive Compound Annual Growth Rate (CAGR) of 110.54% from 2020 to 2024 demonstrates the rapid expansion of the market. Moreover, the growth rate of 52.24% from 2023 to 2024 suggests sustained momentum in the import of human insulin to Cyprus.

The human insulin market in Cyprus is driven by the increasing prevalence of diabetes and demand for advanced diabetes care solutions. This includes insulin products and devices for monitoring and administering insulin, supported by healthcare advancements.
The Cyprus human insulin market is expanding due to the increasing prevalence of diabetes and the rising demand for effective insulin therapies. Advances in insulin delivery systems, such as insulin pens and pumps, are contributing to the growing demand for human insulin in the healthcare sector.
The human insulin market encounters challenges related to the rising prevalence of diabetes and the need for continuous innovation in product formulations. Manufacturers must navigate complex regulatory environments and ensure compliance with safety and efficacy standards, which can complicate product development. Additionally, competition from biosimilars and alternative therapies can pressure pricing and market share.
The human insulin market in Cyprus is vital for managing diabetes, with government initiatives focused on ensuring access to affordable insulin products. Policies support public health programs that raise awareness about diabetes management and provide funding for diabetes care services. Regulatory frameworks ensure the safety and efficacy of insulin products, fostering consumer trust.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Human Insulin Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Human Insulin Market - Industry Life Cycle |
3.4 Cyprus Human Insulin Market - Porter's Five Forces |
3.5 Cyprus Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cyprus Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Cyprus Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Cyprus Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Cyprus Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Human Insulin Market Trends |
6 Cyprus Human Insulin Market Segmentations |
6.1 Cyprus Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Cyprus Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Cyprus Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Cyprus Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Cyprus Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Cyprus Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Cyprus Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Cyprus Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Cyprus Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Cyprus Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Cyprus Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Cyprus Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Cyprus Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Cyprus Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Cyprus Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Cyprus Human Insulin Market Import-Export Trade Statistics |
7.1 Cyprus Human Insulin Market Export to Major Countries |
7.2 Cyprus Human Insulin Market Imports from Major Countries |
8 Cyprus Human Insulin Market Key Performance Indicators |
9 Cyprus Human Insulin Market - Opportunity Assessment |
9.1 Cyprus Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cyprus Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Cyprus Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Cyprus Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Cyprus Human Insulin Market - Competitive Landscape |
10.1 Cyprus Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |